Riskpilot← Back to searchSign inGet full accessVendelsö Djurklinik AB
ABActiveOrg 5569259939Lärjungevägen 4Veterinary activities · NACE 7500Est. 20135-9 employees
Revenue 2024
SEK 7,1M
+26% vs 2023
EBITDA margin
36.7%
+24% vs 2023
Equity ratio
42.1%
Financial strength
Net profit 2024
SEK 1,5M
+28% vs 2023
| Revenue | SEK 7,1M | +26% |
| EBITDA | SEK 2,6M | +24% |
| Net profit | SEK 1,5M | +28% |
| Total assets | SEK 5,6M | +51% |
| Equity | SEK 2,4M | +28% |
| Employees | — | — |
Legal name
Vendelsö Djurklinik AB
Org number
5569259939
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
14 mars 2013
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva veterinär verksamhet, försäljning av foder samt djurtillbehör, hunduppfödning och därmed förenlig verksamhet.
Address
Lärjungevägen 4
Email
info@vendelsodjurklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 503 | 900 | 3 856 | 5 660 | 7 126 |
| Staff expenses | — | — | — | −1 987 | −2 173 |
| EBITDA | 114 | 346 | 807 | 2 114 | 2 614 |
| Depreciation & amort. | −5 | −10 | −86 | −95 | −95 |
| EBIT | 109 | 336 | 721 | 2 018 | 2 518 |
| Net financials | — | — | — | −2 | 44 |
| Profit before tax | 109 | 264 | 540 | 1 507 | 1 922 |
| Tax | −0 | −44 | −115 | −315 | −402 |
| Net profit | 109 | 220 | 425 | 1 192 | 1 520 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 213 | 531 | 1 770 | 3 708 | 5 599 |
| Equity | 152 | 372 | 797 | 1 839 | 2 359 |
| Long-term debt | 0 | 0 | 100 | 150 | 0 |
| Short-term debt | 61 | 88 | 621 | 959 | 1 840 |
| Total debt | 61 | 88 | 721 | 1 109 | 1 840 |
EBITDA margin
36.7%
This company
15.8%
Market median
+132% vs market
20202024
Equity ratio
42.1%
This company
38.2%
Market median
+10% vs market
20202024
Return on equity
64.4%
This company
18.4%
Market median
+250% vs market
20202024
Net profit margin
21.3%
This company
8.1%
Market median
+163% vs market
20202024
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20202024
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PM Chief Executive Officer | Chief Executive Officer | 2022 |
CI Audit | Audit | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vendelsö Djurklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petra Marina Nilsson | Chief Executive Officer | 0 companies |
| Christian Isleyen | Audit | 0 companies |
| Jonathan Robert Renneson | Deputy Board Member | 0 companies |